These effects on survival, dendritic complexity, LTP, and AD sensitivity are quite similar to the ones observed in iGluN2BNes mice at baseline or following chronic FLX treatment suggesting a link between our manipulation of GluN2B expression and BDNF signaling. This evidence concerns the gene GRIN2B and Alzheimer disease.